查看中文
Following a consultation process conducted in June 2024, the Stock Exchange of Hong Kong Ltd. (HKEX) has announced finalized amendments to the Rules Governing the Listing of Securities on HKEX (Listing Rules) to...more
12/31/2024
/ Board of Directors ,
Capital Markets ,
Corporate Governance ,
Diversity ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Investment Management ,
Listing Rules ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Risk Management ,
Shareholders
查看中文
The Stock Exchange of Hong Kong Limited (HKEX) and Securities and Futures Commission (SFC) have announced a temporary relaxation of the minimum market capitalization requirements for Specialist Technology Company...more
8/30/2024
/ Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Popular ,
Private Investment in Public Equity (PIPEs) ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
查看中文
This update primarily provides an overview of key regulatory developments in the second quarter of 2024 relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their...more
8/28/2024
/ Capital Markets ,
China ,
Corporate Governance ,
Derivatives ,
Enforcement ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Lending ,
Listing Rules ,
Loans ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Securities and Exchange Commission (SEC) ,
Securities Regulation ,
Stock Trades
查看中文
In a consultation paper issued in June 2024, The Stock Exchange of Hong Kong Limited (HKEX) is proposing amendments to The Rules Governing the Listing of Securities on HKEX (the Listing Rules) to improve corporate...more
7/5/2024
/ Asia Pacific ,
Board of Directors ,
Capital Markets ,
Corporate Governance ,
Diversity ,
Environmental Social & Governance (ESG) ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Investment Management ,
Listing Rules ,
Proposed Amendments ,
Publicly-Traded Companies ,
Regulatory Agenda ,
Risk Management ,
Shareholders
点击此处阅读调查报告全文
Our fourth annual report on Hong Kong-listed biotech companies examines how the sector performed during the continuing challenging market conditions of the last full calendar year. Although the number of...more
With deep and liquid capital markets offering unique access to the Mainland China investor market, many international businesses are considering pursuing their IPOs in Hong Kong. This summary outlines key issues for companies...more
6/18/2024
/ Acquisitions ,
Asia Pacific ,
Capital Markets ,
China ,
Disclosure Requirements ,
Financial Services Industry ,
Global Market ,
Hong Kong ,
Initial Public Offering (IPO) ,
Intellectual Property Protection ,
Investment ,
Listing Rules ,
Mergers ,
Registration Requirement ,
Regulatory Agenda ,
Regulatory Requirements
查看中文
In its conclusions to a market consultation process held in late 2023, the Stock Exchange of Hong Kong Limited (HKEx) has announced it will permit listed companies to hold their own shares as treasury shares and...more
4/26/2024
/ Asia Pacific ,
Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Listing Rules ,
New Rules ,
Publicly-Traded Companies ,
Shareholders ,
Stock Repurchases
Managing Deal Risks in a Challenging Regulatory Environment: Strategies and Deal Terms With antitrust and other regulators scrutinizing mergers more closely, it is crucial for companies to negotiate terms to mitigate and...more
3/28/2024
/ Acquisitions ,
Antitrust Division ,
Board of Directors ,
Capital Markets ,
China ,
Corporate Entities ,
Corporate Governance ,
Environmental Social & Governance (ESG) ,
Foreign Corporations ,
Global Market ,
Investment Management ,
Legislative Agendas ,
Mergers ,
Private Equity ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Shareholders
On December 29, 2023, China enacted the amended Company Law of the People’s Republic of China (Amended PRC Company Law), which will come into effect on July 1, 2024. These are some of the most significant changes to the laws...more
3/28/2024
/ Asia Pacific ,
Board of Directors ,
Capital Markets ,
China ,
Corporate Counsel ,
Corporate Governance ,
Corporate Officers ,
Foreign Corporations ,
Foreign Investment ,
Investment ,
Legislative Agendas ,
Proposed Legislation ,
Publicly-Traded Companies ,
Shareholders
查看中文
This update provides an overview of key regulatory developments in the fourth quarter of 2023 relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their advisers....more
3/5/2024
/ Board of Directors ,
Capital Markets ,
Corporate Governance ,
Disclosure Requirements ,
Environmental Social & Governance (ESG) ,
Financial Regulatory Reform ,
Foreign Corporations ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Internal Controls ,
Listing Rules ,
Publicly-Traded Companies ,
Regulatory Agenda
Global M&A Activity Endures Headwinds in 2023 and Displays Resilience Going Into 2024 -
Despite market headwinds, dealmakers have looked to carveouts, spin-offs, joint ventures and other creative deal structures to engage...more
12/22/2023
/ Acquisitions ,
Antitrust Provisions ,
Banking Sector ,
Capital Markets ,
China ,
Climate Change ,
Commercial Real Estate Market ,
Competition ,
Controlling Stockholders ,
Corporate Governance ,
Cross-Border ,
EU ,
Exit Strategies ,
Financial Services Industry ,
Geopolitical Risks ,
Global Dealmaking ,
HKEx ,
Insurance Industry ,
Joint Venture ,
Merger Controls ,
Mergers ,
Private Equity ,
Regulatory Agenda ,
Risk Management ,
Securities ,
Short-Term Loans ,
Takeovers ,
Technology Sector ,
UK
The past year presented a complex landscape for China-based companies seeking to access global capital markets. Against a backdrop of challenging macroeconomic conditions and escalating geopolitical tensions, regulatory...more
查看中文
This update provides an overview of key regulatory developments in the third quarter relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their advisers. It covers...more
11/20/2023
/ Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Listing Rules ,
Regulatory Agenda ,
Securities ,
SFC ,
Share Buybacks ,
Shareholders
查看中文
The Stock Exchange of Hong Kong Limited (HKEx) is proposing to permit companies listed on the exchange to hold their own shares as treasury shares and to introduce rules on companies’ resale of treasury shares. The...more
点击此处阅读调查报告全文
Our third annual report on Hong Kong-listed biotech companies examines how the sector performed during the challenging conditions for capital markets globally over the past 12 months. Although aggregate listing...more
4/25/2023
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
Corporate Governance ,
Foreign Corporations ,
Healthcare ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Life Sciences ,
Listing Rules ,
Popular ,
Publicly-Traded Companies
查看中文 -
This January 2023 update provides an overview of key regulatory developments in the past three months relevant to companies listed, or planning to list, on The Stock Exchange of Hong Kong Limited (HKEx) and their...more
2/14/2023
/ Capital Markets ,
Disclosure Requirements ,
Dual Purpose ,
Economic Sanctions ,
Enforcement ,
Environmental Social & Governance (ESG) ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Investigations ,
Investment ,
Investors ,
Listing Rules ,
New Guidance ,
New Regulations ,
Proposed Regulation ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC) ,
Technology Sector
The pandemic’s impact may be subsiding, but businesses are encountering new challenges across the globe, including the potential for an economic retrenchment, rising interest rates, shifting regulatory and litigation...more
12/14/2022
/ Acquisitions ,
Anti-Corruption ,
Antitrust Division ,
Banking Sector ,
Big Tech ,
Board of Directors ,
Bonds ,
Borrowers ,
Capital Markets ,
Capital Raising ,
China ,
Climate Change ,
Convertible Notes ,
Corporate Counsel ,
Corporate Governance ,
Corporate Restructuring ,
Creditors ,
Cross-Border ,
Cryptocurrency ,
Digital Assets ,
Due Diligence ,
Economic Sanctions ,
Enforcement ,
Environmental Social & Governance (ESG) ,
EU ,
Executive Compensation ,
Financial Services Industry ,
Forum Selection ,
Investigations ,
IRS ,
Lenders ,
Mergers ,
Money Laundering ,
Partnerships ,
Publicly-Traded Companies ,
Recessions ,
Repurchases ,
Russia ,
Securities ,
Securities and Exchange Commission (SEC) ,
Securities Litigation ,
Shareholders ,
Special Purpose Acquisition Companies (SPACs) ,
Taxation ,
Technology ,
UK ,
Vertical Mergers
This update provides an overview of key regulatory developments in the past three months relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx) and to their advisers. In particular,...more
With ongoing regulatory developments affecting capital markets globally, many China-related businesses are considering pursuing their IPOs in Hong Kong. However, the regulatory regime for IPOs on the Stock Exchange of Hong...more
Takeaways -
Greater China companies operating in any industry can now obtain secondary listings in Hong Kong, provided they meet market capitalization minimums.
Recent Listing Rules amendments also allow some companies...more
HKEx Finalizes New Rules on Listings for Overseas Issuers -
Following a consultation process conducted earlier in 2021, the Stock Exchange of Hong Kong Limited (HKEx) has announced amended listing rules for overseas...more
This update provides an overview of key regulatory developments in the past three months relevant to companies listed or planning to list on The Stock Exchange of Hong Kong Limited (HKEx), and their advisers. In particular,...more
10/8/2021
/ Capital Markets ,
Corporate Governance ,
HKEx ,
Hong Kong ,
Hong Kong Securities and Futures Commission (HKSFC) ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Listing Rules ,
Private Investment in Public Equity (PIPEs) ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)
With ongoing regulatory developments affecting capital markets globally, many China-related businesses are considering pursuing their IPOs in Hong Kong. However, the regulatory regime for IPOs on the Stock Exchange of Hong...more
Despite the impact of COVID-19 and other recent developments in Hong Kong, the city’s role as a center for China-based companies to raise capital became even more important in 2020. The momentum of several trends that began...more
1/29/2021
/ Biotechnology ,
Capital Markets ,
Capital Raising ,
China ,
Foreign Relations ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
PCAOB ,
Publicly-Traded Companies ,
Securities and Exchange Commission (SEC)
Despite political and economic uncertainties, markets and deal activity were resilient in 2019, and strong fundamentals remain in place heading into 2020. Companies continue to face a challenging litigation and enforcement...more
1/30/2020
/ Acquisitions ,
Administrative Procedure Act ,
Anti-Discrimination Policies ,
Anti-Harassment Policies ,
Anti-Kickback Statute ,
Antitrust Investigations ,
Appeals ,
Arbitration Awards ,
Attorney General ,
Backstop Agreements ,
BEPS ,
BitLicense ,
Blockchain ,
Board of Directors ,
Bonds ,
Capital Markets ,
CFIUS ,
CFTC ,
Chapter 11 ,
Claim Preclusion ,
Class Action ,
Commercial Bankruptcy ,
Common Stock ,
Congressional Investigations & Hearings ,
Congressional Subpoenas ,
Consumer Financial Protection Bureau (CFPB) ,
Cooperation Agreement ,
Copyright ,
Corporate Governance ,
Corporate Restructuring ,
Corporate Social Responsibility ,
Corporate Taxes ,
Corwin Doctrine ,
Covenant Lite Deals ,
Creditors ,
Cross-Border Transactions ,
DACA ,
DE Supreme Court ,
Debt Financing ,
Debtors ,
Department of Justice (DOJ) ,
Dischargeable Debts ,
Disgorgement ,
Disparate Impact ,
Dodd-Frank ,
Down Rounds ,
Drug Pricing ,
EBITDA ,
Employee Retirement Income Security Act (ERISA) ,
Employer Liability Issues ,
Employment Discrimination ,
Enforcement Actions ,
Enforcement of Foreign Judgments ,
Enterprise Act 2002 ,
Environmental Social & Governance (ESG) ,
EU ,
Fair Housing Act (FHA) ,
Federal Trade Commission (FTC) ,
FinTech ,
FIRRMA ,
Foreign Acquisitions ,
Foreign Investment ,
Foreign Issuers ,
FRCP 23 ,
General Data Protection Regulation (GDPR) ,
General Elections ,
GILTI tax ,
High-Yield Markets ,
Hong Kong ,
Hong Kong Stock Exchange ,
Individual Accountability ,
Initial Public Offering (IPO) ,
Intellectual Property Litigation ,
Intercreditor Agreements ,
International Arbitration ,
International Litigation ,
IRS ,
Issue Preclusion ,
Japan ,
Joint Venture ,
Legislative Agendas ,
Life Sciences ,
Listing Rules ,
Litigation Strategies ,
Make-Whole Premium ,
Mergers ,
MFW ,
Multinationals ,
National Security ,
PCAOB ,
Pharmaceutical Industry ,
Political Parties ,
Preferred Shares ,
Private Offerings ,
Privately Held Corporations ,
Proxy Advisory Firms ,
Publicly-Traded Companies ,
Refinancing ,
Regulatory Agenda ,
Reporting Requirements ,
SCOTUS ,
Securities and Exchange Commission (SEC) ,
Securities Litigation ,
Separation of Powers ,
Shareholder Activism ,
Shareholder Proposals ,
Shareholders ,
Split of Authority ,
State Labor Laws ,
Stock Drop Litigation ,
Tax Cuts and Jobs Act ,
Tax Litigation ,
Technology Sector ,
Third-Party Release Agrements ,
Transparency ,
UK ,
UK Brexit ,
Valuation ,
White Collar Crimes